Marshall Wace, LLP Biotech Acquisition CO Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$9.83 - $9.92 $940,731 - $949,344	95,700 Added 10.44%	1,012,642 $10.1 Million
Q4 2021 Feb 14, 2022	BUY	$9.73 - $9.91 $5.85 Million - $5.96 Million	600,918 Added 190.15%	916,942 $9.02 Million
Q3 2021 Nov 15, 2021	BUY	$9.64 - $9.75 $2.08 Million - $2.11 Million	216,038 Added 216.07%	316,024 $3.08 Million
Q1 2021 May 17, 2021	BUY	$9.56 - $9.73 $955,866 - $972,863	99,986 New	99,986 $970,000

Others Institutions Holding BIOT

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Biotech Acquisition Co

Ticker BIOT
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 23,000,000
Description
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

More about BIOT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.